Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
2002 · PubMed · 475 citations
G
Giuseppe Di Lorenzo
Saint Camillus International University of Health and Medical Sciences(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
521
Papers
11.6K
Citations
60
h-index
228
i10-index
Giuseppe Di Lorenzo is an academic researcher from Saint Camillus International University of Health and Medical Sciences. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Renal cell carcinoma treatment & Bladder and Urothelial Cancer Treatments. The author has an h-index of 60, co-authored 443 publications.
ORCID: 0000-0001-7414-1568Papers by this author
worksContinuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
2008 · Breast Cancer Research · 59 citations
https://doi.org/10.1186/bcr2119
Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type
2019 · European Journal of Radiology · 53 citations
https://doi.org/10.1016/j.ejrad.2019.02.018
Her-2/Neu Receptor in Prostate Cancer Development and Progression to Androgen Independence
2004 · Tumori Journal · 48 citations
https://doi.org/10.1177/030089160409000201
A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma
2013 · British Journal of Urology · 35 citations
https://doi.org/10.1111/bju.12564
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).
2023 · Journal of Clinical Oncology · 13 citations
https://doi.org/10.1200/jco.2023.41.6_suppl.469
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat